Clinical Trials and Therapeutics
Issues in the development of practice guidelines for inflammatory bowel disease
Dr. William J. Tremaine,
Corresponding Author
Dr. William J. Tremaine
Inflammatory Bowel Disease Clinic, Mayo Clinic, Rochester, Minnesota, U.S.A.
Address correspondence and reprint requests to Dr. W. J. Tremaine, Mayo Clinic, 200 1st Street, S.W., Rochester, MN 55905, U.S.A.Search for more papers by this authorDr. William J. Tremaine,
Corresponding Author
Dr. William J. Tremaine
Inflammatory Bowel Disease Clinic, Mayo Clinic, Rochester, Minnesota, U.S.A.
Address correspondence and reprint requests to Dr. W. J. Tremaine, Mayo Clinic, 200 1st Street, S.W., Rochester, MN 55905, U.S.A.Search for more papers by this authorFirst published: 14 December 2006
References
- 1 Institute of Medicine. Guidelines for clinical practice: from development to use. Washington, DC: National Academic Press, 1992.
- 2 Phelps CE. The methodologic foundations of studies of the appropriateness of medical care. N Engl J Med 1993; 329: 1241–5.
- 3 Brooks RH. Practice guidelines and practicing medicine: are they compatible? JAMA 1989; 262: 3027–30.
- 4 McDonald CJ. Medical heuristics: the silent adjudicators of clinical practice. Ann Intern Med 1996; 124: 56–62.
- 5 Guyatt G, Cairns J, Churchill D, Cook D, Haynes B, Hirsh J, Irvine J, Levine M, Levine M, Nishikawa J, Sackett D. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA 1992; 268: 2420–5.
- 6 Gray JAM, Haynes RB, Sackett DL, Cook DJ, Guyatt GH. Transferring evidence from research into practice: 3. Developing evidence-based clinical policy. ACP Journal Club 1997; 126: A14–6.
- 7 Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Intern Med 1995; 123: 132–42.
- 8 Kornbluth AA, Salomon P, Sacks HS, Metty R, Janowitz HD. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol 1993; 16: 215–8.
- 9 Steinhart HA, Hemphill D, Greenberg GR. Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Am J Gastroenterol 1994; 89: 216–24.
- 10 Chalmers I, Dickersin K, Chalmers TC. Getting to grips with Archie Cochrane's agenda. BMJ 1992; 305: 786–8.
- 11 Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults. Am J Gastroenterol 1997; 92: 204–11.
- 12 Hanauer SB, Meyers S. Management of Crohn's disease in adults. Am J Gastroenterol 1997; 92: 559–66.
- 13 Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98: 1123–8.
- 14 Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Batts KP, Croghan IT, Dale LC, Schroeder KR, Hurt RD. Transdermal nicotine for mildly to moderately active ulcerative colitis. Ann Intern Med 1997; 126: 364–71.
- 15 Trnka YM, La Mont JT. Association of Clostridium difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology 1981; 80: 696–706.
- 16 Evans JMM, McMahon AD, Murray FE, McDevitt DG, Mac Donald TM. Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. Gut 1997; 40: 619–22.
- 17 Robertson DA, Ray J, Diamond I, Edwards JG. Personality profile and effective state of patients with inflammatory bowel disease. Gut 1989; 30: 623–6.
- 18 North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease? A prospective study. Ann Intern Med 1991; 114: 381–6.
- 19 Satsangi J, Jewell DP. The genetics of inflammatory bowel disease. Gut 1997; 572–4.
- 20 Drossman DA. Quality of life issues in Crohn's disease. In: C Prantera, BI Korelitz, eds. Crohn's disease. New York: Marcel Dekker, 1996: 445–51.
- 21 Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522–3.
- 22 Silverberg MS, Mikolainis S, Steinhart AH. Osteopenia in patients with Crohn's disease [Abstract]. Gastroenterology 1997; 112: A1092.
- 23 Schulte C, Weilenmann-Krüger H Dignaß A, Mann K, Goebell H. Osteopenia in patients with IBD is caused by increased bone resorption and suppressed bone formation [Abstract]. Gastroenterology 1997; 112: A1086.
- 24 Barton JR, Ferfuson A. Failure to record variable of growth and development in children with inflammatory bowel disease. BMJ 1989; 298: 865–6.
- 25 Gazzard BG, Price HL, Libby GW, Dawson AM. The social toll of Crohn's disease. BMJ 1978; 2: 1117–21.
- 26 Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. Clin Gastroenterol 1993; 17: 214.
- 27 Mort EA, Edwards JN, Emmons DW, Convery K, Blumenthal D. Physicians response to patient insurance status in ambulatory care clinical decision-making: implications for quality of care. Med Care 1996; 34: 783–97.
- 28 Holcombe RF, Griffin J. Effect of insurance status on pain medication prescriptions in a hematology/oncology practice. S Med J 1993; 86: 151–6.
- 29 Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934–44.
- 30 Lang DM, Sherman MS, Polansky M. Guidelines and realities of asthma management: the Philadelphia Story. Arch Intern Med 1997; 157: 1193–200.
- 31 Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: 1317–22.
- 32 Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best evidence for clinical decisions. Ann Intern Med 1997; 126: 376–80.
